Zhenghai Biology: The company currently has no plans to develop non-animal derived meningeal product series.

On August 26, Pacific Pharmaceuticals stated on the interactive platform that the company's calcium-silicon bioceramic bone repair material belongs to non-animal source synthetic bone repair materials. After the product is launched and sold in the future, it will be subject to a 13% value-added tax. The company currently has no plans to develop non-animal source meningeal products.